Pointe Capital Management’s Gilead Sciences GILD Stock Holding History

Pointe Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-621	Closed	-$51.5K	–	247
2023 Q1	$51.5K	Buy	+621	New	+$51.4K	0.04%	228
2018 Q4	–	Sell	-2,685	Closed	-$207K	–	144
2018 Q3	$207K	Sell	2,685 -380	-12%	-$28.7K	0.16%	146
2018 Q2	$217K	Sell	3,065 -555	-15%	-$39.2K	0.19%	136
2018 Q1	$273K	Hold	3,620	–	–	0.24%	124
2017 Q4	$259K	Sell	3,620 -3,515	-49%	-$267K	0.21%	133
2017 Q3	$578K	Sell	7,135 -3,000	-30%	-$229K	0.43%	71
2017 Q2	$717K	Buy	10,135 +6,080	+150%	+$405K	0.51%	54
2017 Q1	$275K	Buy	+4,055	New	+$285K	0.21%	125
2016 Q4	–	Sell	-4,522	Closed	-$358K	–	188
2016 Q3	$358K	Hold	4,522	–	–	0.26%	113
2016 Q2	$377K	Sell	4,522 -3,905	-46%	-$347K	0.27%	106
2016 Q1	$774K	Buy	8,427 +197	+2%	+$17.8K	0.61%	49
2015 Q4	$833K	Sell	8,230 -604	-7%	-$62.8K	0.6%	48
2015 Q3	$867K	Buy	8,834 +175	+2%	+$19.4K	0.53%	50
2015 Q2	$1.01M	Buy	8,659 +1,871	+28%	+$204K	0.46%	56
2015 Q1	$666K	Buy	+6,788	New	+$689K	0.31%	65

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pointe Capital Management's GILD Position: Q2 2023 in Review

Pointe Capital Management sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 621 shares — an estimated $51.5K sold.

Pointe Capital Management first reported a position in GILD in Q1 2015 and held it in 15 quarters. The position peaked at $1.01M in Q2 2015. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

Pointe Capital Management reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
Pointe Capital Management sold 621 Gilead Sciences shares in Q2 2023, an estimated $51.5K.
Pointe Capital Management first reported a position in Gilead Sciences in Q1 2015 and held it in 15 quarters.
Pointe Capital Management's Gilead Sciences position peaked at $1.01M in Q2 2015.
1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Pointe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.